The global automated nucleic acid extraction market size was valued at US$ 3.6 Bn in 2025 and is projected to reach US$ 11.7 ...
Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...
The investment will expand RNA Technologies & Therapeutics’ operations and allow partners of both companies to leverage ...
Changes in genes have been linked to the development of different diseases for a while. However, it's not exactly clear what ...
In addition to its Chinese R&D and manufacturing centers in Beijing and Suzhou, Ribo also set up a subsidiary, Ribocure AB, ...
Alloy Therapeutics today announced the appointment of Christian Cobaugh, Ph.D., as Chief Executive Officer of Alloy Genetic ...
A research team at The University of Osaka revealed that the loss of heterochromatin can cause a chain reaction leading to ...
Cholera remains a major global public health challenge, with an estimated 1.3 to 4 million cases and tens of thousands of ...
Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform ...
Researchers at Utah State University revealed new details about CRISPR immune system defenses, such as Cas12a3 systems, that ...
News-Medical.Net on MSN
Scientists reveal how cholera bacteria activate toxin genes in the human gut
Cholera remains a major global public health challenge, with an estimated 1.3 to 4 million cases and tens of thousands of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback